Purchase Order 75N94023P00685
Award Date 9/9/23
Potential Completion Date 9/8/24
Potential Value $15K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bohemia, NY 11716, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price purchase order to Sartorius Corporation for annual service maintenance of an IncuCyte S3 live-cell analysis system (Serial #IC51363). This $15,969.50 contract, issued on September 1, 2025, with completion by August 31, 2026, supports the agency's biomedical research operations. Sartorius Corporation, a subsidiary of German multinational Sartorius Aktiengesellschaft headquartered in Bohemia,...
- Sartorius Corporation has been awarded a $20,767 firm fixed price purchase order by the National Institutes of Health's National Cancer Institute to provide maintenance services in Bohemia, New York through February 2025. As a manufacturer and solutions provider for biopharmaceutical and laboratory customers, Sartorius Corporation will deliver equipment upkeep to support the agency's biomedical research programs. No set-aside designation was specified for this award. Sartorius has a track record...
- Sartorius Corporation has been awarded a $18,270 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide INCUCYTE SX5 SOFTWARE/SERVICE WARRANTY under contract number 2201207. Place of performance will be in Bethesda, Maryland, with a period of performance from May 1, 2024 through April 30, 2025. As the prime contractor, Sartorius Corporation will deliver software and service...
- Sartorius Corporation has been awarded a $15,656 firm fixed price purchase order by the National Institutes of Health's National Cancer Institute for maintenance services. The contract has no set-aside designation and requires performance through February 2025 in Bohemia, New York. As a prime contractor and manufacturer of laboratory equipment and consumables, Sartorius Corporation will provide maintenance to support the National Cancer Institute's biomedical research programs. Honeywell...
- Sartorius Corporation has been awarded a one-year, firm fixed price purchase order valued at $15,656 by the National Institutes of Health Clinical Center to provide equipment used for research by the Critical Care Medicine Department. As a manufacturer of laboratory goods, Sartorius Corporation will serve as the prime contractor to supply the necessary biomedical equipment, software, maintenance, and repair services to support research programs at the NIH Clinical Center. No set-aside...
- Sartorius Corporation has been awarded a $15,272.50 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide replacement octet biosensors for an existing octet system. The octet system is used to study biomolecular interactions and is a key tool supporting NIH's research into infectious diseases. Sartorius Corporation, a division of Germany-based Sartorius Aktiengesellschaft, will manufacture and deliver the...
- This federal contract award, with an ID of HHSN267200700593P, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The contract, a $149,842 firm-fixed-price purchase order, was awarded to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries. The contract, which did not have a...
- Sartorius Corporation has been awarded a $10,660 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to repair an existing Octet Red 384 instrument. As the prime contractor, Sartorius Corporation will perform the repair work itself at its facility in Bohemia, New York. The funding agency, HHS's NIH, supports medical research to improve public health, including in the areas of allergies and infectious diseases. No...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,386.50 firm fixed price purchase order to Sartorius Corporation for OCTECT streptavidin biosensors. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will deliver the requested products from its location in Bohemia, New York by September 29, 2023 in support of the NIH/NIAID's research efforts to develop new tools for biomedical...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Sartorius Corporation valued at $44,587.40 on February 23, 2021, with completion by March 3, 2021. The order is firm fixed price with no small business set-aside. Performance occurs in Bohemia, New York. Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions for the biopharmaceutical and life sciences industries, supplies specialized biomedical research tools and services to...
Sartorius Corporation has been awarded a $14,544.50 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to provide unspecified goods or services. Performance will take place in Bohemia, New York over a one year period from September 2023 through September 2024. As a subsidiary of Sartorius Aktiengesellschaft, Sartorius Corporation will serve as the prime contractor on this contract associated with the NIH's research efforts related to diabetes, digestive diseases, and kidney disease. No subcontractors or set aside designations were indicated.
Generated 12/21/23, 11:45 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 8/10/23 |